Logo Image

Shorts

Why You Shouldn't Wait to Treat MDS
0:31
Why You Shouldn't Wait to Treat MDS
3 months ago
by
David Sallman, MD
My Strategy for MDS Patients Waiting Transplant
0:32
My Strategy for MDS Patients Waiting Transplant
3 months ago
by
David Sallman, MD
Why Haven't Trial Participation Rates Improved?
0:50
Why Haven't Trial Participation Rates Improved?
3 months ago
by
Inna Gong, MD, PhD
Combating Misinformation: The Truth About the HPV Vaccine
0:55
Combating Misinformation: The Truth About the HPV Vaccine
3 months ago
by
Natalie Berger, MD
Are We Being Too Strict With Clinical Trial Eligibility?
0:30
Are We Being Too Strict With Clinical Trial Eligibility?
3 months ago
by
Christine Bestvina, MD
Why Lung Cancer is Now "12 Different Diseases"
0:33
Why Lung Cancer is Now "12 Different Diseases"
3 months ago
by
Christine Bestvina, MD
MajesTEC-3 Outcomes Lead to Rapid Myeloma Combo Approval
1:04
MajesTEC-3 Outcomes Lead to Rapid Myeloma Combo Approval
4 months ago
by
Luciano Costa, MD, PhD
The Problem With MRD Testing in Breast Cancer
0:47
The Problem With MRD Testing in Breast Cancer
4 months ago
by
Paolo Tarantino, MD
How Mezigdomide Reinvigorates the Immune System
1:30
How Mezigdomide Reinvigorates the Immune System
4 months ago
by
Paul G. Richardson, MD
Mapping Therapy-Driven Immune Changes in Metastatic PDAC
0:31
Mapping Therapy-Driven Immune Changes in Metastatic PDAC
4 months ago
by
Won Jin Ho, MD
Is 2026 the Pivotal Year for Liquid Biopsies in Breast Cancer?
1:08
Is 2026 the Pivotal Year for Liquid Biopsies in Breast Cancer?
4 months ago
by
Paolo Tarantino, MD
Overlaps in Breast and Gynecologic Cancer Treatments
0:39
Overlaps in Breast and Gynecologic Cancer Treatments
4 months ago
by
Natalie Berger, MD
The Future of Personalized Kidney Cancer Treatment
0:34
The Future of Personalized Kidney Cancer Treatment
4 months ago
by
Karie Runcie, MD
Predicting Melanoma Treatment Success After 3-4 Weeks
1:30
Predicting Melanoma Treatment Success After 3-4 Weeks
4 months ago
by
Vincent Ma, MD
Intravesical Erdafitinib Evaluated in Phase 1 NMIBC Trial
0:55
Intravesical Erdafitinib Evaluated in Phase 1 NMIBC Trial
4 months ago
by
Antoni Vilaseca Cabo, MD
Exploring Immune Data to Guide Pancreatic Cancer Immunotherapy
0:42
Exploring Immune Data to Guide Pancreatic Cancer Immunotherapy
4 months ago
by
Won Jin Ho, MD
How MRD Could Fast-Track Cancer Breakthroughs
0:41
How MRD Could Fast-Track Cancer Breakthroughs
4 months ago
by
Sagar Lonial, MD, FACP
Why Bone Health Is Crucial in Prostate Cancer Treatment
1:03
Why Bone Health Is Crucial in Prostate Cancer Treatment
4 months ago
by
Daniel P. Petrylak, MD
Why PSMA PET Is the New Gold Standard for Prostate Cancer
0:38
Why PSMA PET Is the New Gold Standard for Prostate Cancer
4 months ago
by
Scott Tagawa, MD, MS, FACP, FASCO
Impressive Durability in New Cancer Combo Therapy
0:35
Impressive Durability in New Cancer Combo Therapy
4 months ago
Dr Hoehn on a More Equitable Approach to Clinical Trials
0:28
Dr Hoehn on a More Equitable Approach to Clinical Trials
4 months ago
by
Richard Hoehn, MD
A Breakthrough in Renal Cell Carcinoma Treatment
0:40
A Breakthrough in Renal Cell Carcinoma Treatment
4 months ago
by
Yousef Zakharia, MD
How ctDNA and Genomics Are Changing Modern Oncology
0:55
How ctDNA and Genomics Are Changing Modern Oncology
4 months ago
by
Kevin Kalinsky, MD, MS
ctDNA: The Future of Detecting Cancer Recurrence
0:24
ctDNA: The Future of Detecting Cancer Recurrence
4 months ago
by
Estelamari Rodriguez, MD, MPH
T-Cell Engagers Look Promising in Prostate Cancer
0:56
T-Cell Engagers Look Promising in Prostate Cancer
4 months ago
by
Sandy Srinivas, MD
Turning “Negative” PDAC Trials Into Future Breakthroughs
0:17
Turning “Negative” PDAC Trials Into Future Breakthroughs
4 months ago
by
Dimitrios Sidiropoulos, PhD
The Flaw in Current Prostate Cancer Biomarkers
1:00
The Flaw in Current Prostate Cancer Biomarkers
4 months ago
by
Michael S. Leapman, MD, MHS
Understanding Bone Protective Agents
0:37
Understanding Bone Protective Agents
4 months ago
by
David R. Wise, MD, PhD
Test First, Treat Second: ASCO's Updated Approach to Driver Mutation–Negative NSCLC
1:14
Test First, Treat Second: ASCO's Updated Approach to Driver Mutation–Negative NSCLC
4 months ago
by
Joshua Reuss, MD
The “Donut” Pattern of Clinical Trial Enrollment
0:30
The “Donut” Pattern of Clinical Trial Enrollment
4 months ago
by
Richard Hoehn, MD